Find discounts on prescription drugs for pharmacies near you with FlexPerx Rx where we help you save money on over thousands of drugs and medicines.

A deal with pharmaceutical companies may not be as far-reaching as the administration says, according to experts.

LB 457 limits EpiPen out-of-pocket costs to $60 for a two-pack annually.

Murray proposes legislation to safeguard 340B contract pharmacies in Massachusetts.

SB589 requires discounted outpatient medications for low-income patients under the 340B program

Department of Health sets penalties for noncompliance and develops rules for 340B program.

Senate bill 875 aims to address pharmacy access issues and amend conflict of interest provisions.

© Reuters. U.S. dollar banknote and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration/File Photo "I look forward to working with you on legislation or any way that we can to get there," Kennedy said in response to a question from Senator Bernie Sanders, an independent who votes with Democrats. Which stock should you buy in your very next trade? AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar? Unlock ProPicks AI 0 Latest comments 1D 1W 1M 6M 1Y 5Y Max US 30 42,063.50 -76.9 -0.18% US 500 5,886.60 +0.1 0.00% Dow Jones 42,062.65 -77.78 -0.18% S&P 500 5,887.13 +0.58 +0.01% Nasdaq 19,105.12 +95.03 +0.50% S&P 500 VIX 18.21 -0.01 -0.05% Dollar Index 100.952 +0.126 +0.12% Most Popular Articles News Analysis NVIDIA, AMD targets raised at BofA following sovereign AI deals By Investing.co... May 14, 2025 Bitcoin price today: flat at $103.5k after soft US CPI, US-China trade truce By Investing.co... May 14, 2025 UBS expects U.S. tariff rate to settle near 15% by year-end By Investing.co... May 14, 2025 Will the U.S. recession ever come? BofA weighs in By Investing.co... May 14, 2025 More News Market Movers Name Last Chg. % Vol. NVDA 134.92 +3.84% 213.53M SMCI 45.01 +15.74% 144.64M TSLA 346.92 +3.85% 114.58M PLTR 130.00 +1.48% 83.40M AMD 117.28 +4.28% 74.39M GOOGL 165.03 +3.45% 38.52M UNH 311.47 +0.03% 29.55M Trending Stocks Name Last Chg. % Vol. NVDA 134.92 +3.84% 213.53M TSLA 346.92 +3.85% 114.58M SMCI 45.01 +15.74% 144.64M UNH 311.47 +0.03% 29.55M PLTR 130.00 +1.48% 83.40M Show more Install Our AppScan QR code to install app Google Play App Store Blog Mobile Portfolio Widgets About Us Advertise Help & Support Authors Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Healthcare leaders emphasize 340B program's crucial role in providing affordable medications in rural areas.

Senate Bill 646 mandates regulations on insulin analogs effective January 1, 2026.

New Mexico bill prohibits discrimination against 340B entities in drug pricing.

New York advances Affordable Drug Manufacturing Act to produce generics and reduce healthcare costs.

House bill 1242 protects pharmacy access and limits drug manufacturer data demands in Tennessee.

New rules prevent interference with 340B entities' contracts and discount access.